Reducing tumor heterogeneity with TTFields prevents glioblastoma recurrence through a combination therapy

Raw data referred to the manuscript "Reducing tumor heterogeneity with TTFields prevents glioblastoma recurrence through a combination therapy" submitted for publication. Glioblastoma recurrence reflects dynamic tumor adaptation to therapy. TTFields stimulation promotes mesenchymal reprogramming and upregulates tmCLIC1 in recurrent tumors. tmCLIC1 inhibition, combined with TTFields, suppresses tumor growth and prevents recurrent glioblastoma. The uploaded files' raw data are related to the figures of the paper. Additional information, results of each experiment and quantification of all the measurements reportend in the main manuscript.